Buy or sell Contraline stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

View More Companies

Contraline Stock

Contraline is developing the first long-lasting, reversible contraceptive for men

Founded

2015

Headquarters

Charlottesville VA, US

Total Funding

$2.9M

About Contraline Stock

Contraline is a biotechnology company developing a long-lasting, non-hormonal, and reversible male contraceptive.

Funding History

July 2014$0
June 2016$680K
March 2017$2.3M
July 2018$0
September 2018$0

Management

COO

Nicole E. Hastings

Co-Founder & CEO

Kevin Eisenfrats

Press

Other Companies

23andMe Logo
Learn More
Learn More
23andMe
Human genome research
$792MTotal Funding
Baxter International Logo
Learn More
Learn More
Baxter International
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people.
$0Total Funding
Cresco Labs Logo
Learn More
Learn More
Cresco Labs
Enhancing the lives of Illinois medical cannabis patients and inciting the progressive evolution of the medical cannabis industry.
$104MTotal Funding
Personalis Logo
Learn More
Learn More
Personalis
Contract research organization and genome-scale diagnostics services company
$75.0MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Contraline or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo